Craig Foster, Ondo InsurTech, discusses the expanded partnership with Nationwide in the US. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.70
Bid: 13.70
Ask: 14.00
Change: -0.05 (-0.36%)
Spread: 0.30 (2.19%)
Open: 13.70
High: 13.70
Low: 13.70
Prev. Close: 13.90

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HY2025 Trading Update

9 Oct 2024 07:00

RNS Number : 4432H
Revolution Beauty Group PLC
09 October 2024
 

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

HY2025 trading update

Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, is today providing an update on trading for the six months ended 31 August 2024.

First half financial summary

Total net sales in the first half of FY25 declined 20% to £72m (HY24: £90m), driven by the planned simplification of the product portfolio and the associated discontinuation of unproductive SKUs. The decline also reflects significant stock clearance activity in the first half of FY24.

By contrast, the net sales from the Company's core range of SKUs grew 6% in the first half, with growth accelerating to 16% in the second quarter versus the prior year.

Excluding stock provisions, Underlying Adjusted EBITDA was £3.1m in the first half (HY24: £3.5m(1)). Underlying sales channel margins improved as efficiencies and cost savings were realised from running a simplified brand portfolio. The Group's cost savings programmes remain on track, with operating costs, excluding marketing costs, decreasing 31% and administrative costs decreasing 25% year on year. Marketing increased 8% versus prior year, with investments in brand marketing to underpin future growth of core products.

As previously disclosed, Revolution Beauty continues to focus on clearing slow-moving discontinued inventory from previous years to generate cash. As a result, the Group has determined that it is necessary to recognise a one-off, non-cash stock provision of £11.3m in the first half to reflect the Net Realisable Value of the remaining old inventory, which will be excluded from Underlying Adjusted EBITDA. This will allow management to realise value and generate cash for future operations.

The Company had cash balances of £6.8m at 31 August 2024 and a fully drawn RCF of £32 million.

FY25 outlook

Reflecting the Group's first half performance, Revolution Beauty is updating its full year guidance. Sales for FY25 are now expected to decline year on year at a slightly slower rate than in H1, with a return to growth in the fourth quarter as a number of the Group's new strategic growth initiatives take effect, and this growth is expected to accelerate through FY26.

With the continuing momentum in the underlying business, as gross margins further strengthen in the second half of the year and as cost saving programmes continue to deliver, Underlying Adjusted EBITDA is expected to be at least in line with FY24 as previously guided, prior to the one-off stock provision.

Strategic progress

Revolution Beauty has continued to deliver on its Reigniting the Revolution strategy during the first half. This includes encouraging progress with existing and new retailers, through both digital and physical channels.

The Group has agreed a new relationship with DM Germany, Germany's number one mass beauty retailer, where Revolution Beauty will launch in more than 850 stores in January 2025. Revolution Beauty is also expanding into 250 new Boots stores in the UK in October 2024. In the US, Walmart will carry a full assortment of Revolution Beauty products in more than 1800 stores from January 2025, and its new Amazon US shop, launched in HY25, is growing ahead of plan.

Lauren Brindley, Revolution Beauty CEO, commented:

"In the last six months, we have made great progress in our Reigniting the Revolution strategy. We have reduced our SKU portfolio significantly, enabling improved underlying gross margin performance, on a core set of SKUs that are growing globally. This year is a transformational year for the Company, as we focus on simplifying the business, improving our operational efficiency and positioning ourselves for profitable and sustained success.

We expect a return to growth in Q4, as we begin landing our new growth initiatives, including a reinvigorated pipeline of make-up innovation, the launch of our new Skincare range and the global expansion of our budget brand, Relove. I remain highly confident that our Reigniting the Revolution strategy will deliver attractive, long-term, profitable growth."

Revolution Beauty expects to announce its results for the half year ended 31 August 2024 in November.

(1) Underlying Adjusted EBITDA for FY24 calculated as Adjusted EBITDA of £6.4m less stock provision benefit of £3.1m

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, please contact:

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

Joint Corporate Brokers

Panmure Liberum Capital Limited (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

Zeus: Benjamin Robertson / Nick Cowles / Jordan Warburton

Tel: +44 (0) 161 831 1512

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRARSSURRUA
Date   Source Headline
8th Nov 20247:00 amRNSNotice of HY25 Results
4th Nov 20247:00 amRNSNominated Adviser and Broker
4th Nov 20247:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSHY2025 Trading Update
7th Oct 202412:40 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSRelated party transactions
5th Sep 20244:56 pmRNSHolding(s) in Company
30th Aug 20244:11 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:59 pmRNSAnnual General Meeting
29th Jul 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jul 20247:00 amRNSNotice of Retail Investor Presentation
3rd Jul 20245:00 pmRNSNotice of AGM and posting of Annual Report
1st Jul 202412:00 pmRNSTotal Voting Rights and NOMAD name change
26th Jun 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 29 FEBRUARY 2024
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.